Ads
related to: budesonide formoterol inhaler brand name- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- Important Safety Info
Read About Safety & Side Effects
For An Asthma Triple Therapy.
- Resources & Information
Access Resources & Important Info
For An Asthma Therapy Here.
- Dosing Information
Search results
Results From The WOW.Com Content Network
Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide , a steroid ; and formoterol , a long-acting β 2 -agonist (LABA). [ 2 ]
Budesonide/glycopyrronium bromide/formoterol, sold under the brand name Breztri Aerosphere among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). [5] [6] [7] It contains budesonide, glycopyrronium bromide, and formoterol fumarate dihydrate. [5] [6] [7] It is inhaled. [5 ...
Inhaler for a powder based in budesonide and formoterol. Formoterol is marketed in three forms: a dry-powder inhaler (DPI), a metered-dose inhaler (MDI) and an inhalation solution, under various brand names including Atock, Atimos/Atimos Modulite, Foradil/Foradile, Fostair, Oxeze/Oxis, Perforomist and Symbicort.
Budesonide, sold under the brand name Pulmicort, among others, is a steroid medication. [8] It is available as an inhaler , nebulization solution , pill , nasal spray , and rectal forms . [ 8 ] [ 9 ] The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Previously used metered-dose inhaler of Serevent-brand salmeterol A typical dry-powder inhaler salmeterol "diskus" Salmeterol, first marketed and manufactured by Glaxo (now GlaxoSmithKline, GSK) in the 1980s, was released as Serevent in 1990. [6] The product is marketed by GSK under the Allen & Hanburys brand in the UK. [citation needed]
Revefenacin, sold under the brand name Yupelri, is a medication for the treatment of chronic obstructive pulmonary disease (COPD). It was approved for use in the United States in 2018. [1] It was developed by Theravance Biopharma and is marketed by Mylan. Revefenacin is formulated as a solution that is nebulized and inhaled. [2]
Ads
related to: budesonide formoterol inhaler brand name